APOE2 reduces risk of Alzheimer's disease by protection of lysosomes from lipid overloading

APOE2 reduces risk of Alzheimer's disease by protection of lysosomes from lipid overloading

Saved in:

Bibliographic Details
Main Authors:	Jing Feng, Xiwen Ma, Jianping Ye
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	APOE2 APOE3 APOE4 Lipofuscin LDLR Alzheimer's disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383525001200
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The effect of ApoE e4 on blood pressure in patients with and without depression
by: Hestad K, et al.
Published: (2016-06-01)

Microglial ApoD‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression
by: Yaliang Yu, et al.
Published: (2025-05-01)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
by: Camilla Steen Jensen, et al.
Published: (2019-01-01)

Gut microbiota distinguishes aging hispanics with Alzheimer’s disease: associations with cognitive impairment and severity
by: Vanessa Sepúlveda-Rivera, et al.
Published: (2025-08-01)

Effect of Fermented Food Products as Vitamin K Dietary Sources on the Development of Atherosclerotic Lesions in ApoE/LDLR<sup>−/−</sup> Mice
by: Magdalena Franczyk-Żarów, et al.
Published: (2024-02-01)

Accelerated midlife endocrine and bioenergetic brain aging in APOE4 females
by: Tian Wang, et al.
Published: (2025-08-01)

APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses
by: Cassi M. Friday, et al.
Published: (2025-08-01)

Regional analysis of APOE polymorphism in Alzheimer’s disease in Spain
by: Ignacio Pardo-Pérez, et al.
Published: (2025-04-01)

Chronic RNA G-quadruplex accumulation in aging and Alzheimer’s disease
by: Lena Kallweit, et al.
Published: (2025-02-01)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
by: I. K. Malashenkova, et al.
Published: (2018-06-01)

TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease
by: Jia Lu, et al.
Published: (2024-10-01)

Hypertension a Predictive Risk Factor on Progression to Alzheimer’s Disease Using APOEε4 as a Benchmark
by: Mingfei Li, et al.
Published: (2025-04-01)

Exploring the impact of APOE ɛ4 on functional connectivity in Alzheimer’s disease across cognitive impairment levels
by: Kangli Dong, et al.
Published: (2025-01-01)

APOE-ε4 polymorphism and cognitive deficit among the elderly population of Fernando de Noronha Polimorfismo de APOE-ε4 e déficit cognitivo na população idosa de Fernando de Noronha
by: Anália Nusya Garcia, et al.
Published: (2008-06-01)

ApoB/ApoA-Ι is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year
by: Jie Zhang, et al.
Published: (2025-01-01)

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
by: Anthony J Hinrich, et al.
Published: (2016-02-01)

APOE epsilon4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies Asociación positiva entre APOE épsilon4 y demencia de Alzheimer en una serie clinica en Bogotá (Colombia) y revision de los estudios latinoamericanos
by: Martine Jacquier, et al.
Published: (2001-03-01)

APOE4 triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly
by: Feng Chen, et al.
Published: (2025-06-01)

Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults
by: Larissa Fischer, et al.
Published: (2025-04-01)

Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups
by: Seraphina K. Solders, et al.
Published: (2025-01-01)

Linking the low‐density lipoprotein receptor‐binding segment enables the therapeutic 5‐YHEDA peptide to cross the blood‐brain barrier and scavenge excess iron and radicals in the brain of senescent mice
by: Zhenyou Zou, et al.
Published: (2019-01-01)

Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease
by: Chelsea N. Johnson, et al.
Published: (2025-06-01)

Apolipoprotein E4 and Alzheimer's disease in São Paulo - Brazil Apolipoproteina E 4 e doença de Alzheimer em São Paulo - Brasil
by: Osvaldo P. Almeida, et al.
Published: (1997-01-01)

Association between apolipoprotein E ε4 status and the risk of Alzheimer’s disease: a meta-analysis
by: Zijun Ren, et al.
Published: (2025-01-01)

When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis
by: Jagadeesh Narasimhappagari, et al.
Published: (2025-08-01)

Research Progress in the Study of Traditional Chinese Herbal Medicine Extracts Regulating Ferroptosis thus Improving the Symptom of Alzheimer's Disease
by: PEI Jinying, SONG Jinzhou, MA Daofeng, LUO Xiaoting, LIU Bin, DONG Xiaohong, CONG Shuyuan
Published: (2025-02-01)

ApoE2 affects insulin signaling in the hippocampus and spatial cognition of aged mice in a sex-dependent manner
by: Yu Wang, et al.
Published: (2025-02-01)

Bioinformatic and genomic analysis identifies C allele of APOE rs7412 as the most prominent variant limiting extreme human longevity
by: Rahmat Dani Satria, et al.
Published: (2025-07-01)

Pelatihan Implementasi Guided Discovery Learning Berbasis APOS pada Guru-guru SMP Plus Al-Azhar
by: Oom Rohmah Syamsudin, et al.
Published: (2021-10-01)

Pelatihan Implementasi Guided Discovery Learning Berbasis APOS pada Guru-guru SMP Plus Al-Azhar
by: Oom Rohmah Syamsudin, et al.
Published: (2021-10-01)

Pelatihan Implementasi Guided Discovery Learning Berbasis APOS pada Guru-guru SMP Plus Al-Azhar
by: Oom Rohmah Syamsudin, et al.
Published: (2021-10-01)

Corrigendum: Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with APOEε4 and mild cognitive impairment
by: Jason Mares, et al.
Published: (2024-09-01)

Protocol of a randomized, single-blind, controlled trial of an 18-month, home-based, high-intensity, exercise intervention in older, cognitively unimpaired APOE ε4 carriers
by: Stephen M. Rao, et al.
Published: (2025-05-01)

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
by: Yury Loika, et al.
Published: (2024-10-01)

Search for the elusive haplotype of the APOE polymorphism associated with Alzheimer’s disease
by: Asma Naseer Cheema, et al.
Published: (2025-05-01)

Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer’s Disease: An Observational Case-Control Study
by: Laura Bello-Corral, et al.
Published: (2024-11-01)

Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
by: Carolyn M. Langlois, et al.
Published: (2019-01-01)

APOE genetic variability in an Egyptian cohort of PD
by: Eman M. Khedr, et al.
Published: (2025-05-01)

Discovery of Isobavachin, a Natural Flavonoid, as an Apolipoprotein E4 (ApoE4) Structure Corrector for Alzheimer’s Disease
by: Sachin P. Patil, et al.
Published: (2025-02-01)

Association between diffusion MRI-based measures of neurite microstructure and risk of Alzheimer's disease
by: Sasha Hakhu, et al.
Published: (2025-07-01)